NURS 4005 – Week 2 Discussion – Providing Genetic Nursing Care to Patients With Chronic Illnesses
Pharmacogenomics is known as the study of drug responses and the effects it has on any one or group of individuals based on their DNA makeup. The term “genomics” was derived in 1986 by Tom Roderick, where it was defined as the study of genomes (Pranavchand & Reddy, 2016). As medicine and technology continue to improve and vastly develop, physicians and scientists aim to create medicine to cater to patients based on their genetic composition (Veilleux et al., 2020). The article selected discusses how genomic indicators are being used to manage patient treatment and to determine the actual need based on the patient’s diagnoses paired with their genetic makeup. Veilleux et al. (2020) used a theory-based approach when conducting this study, including 36 studies. This relates to nursing practice in the way that we are the frontline caring for the patient and addressing pain and their chief complaints. We collect the data that is needed for these studies to take place.
As bedside nurses, we assess pain levels as part of the patient’s vital signs. We also triage to gather information so that adequate care is provided. The first point of contact with the patient, the nurse, also collects demographic information and enters it into the system, which provides all providers with a bigger picture of how to treat the patient’s symptoms. Our role as nurses is to collect the data that is appropriate to be able to enable the use of pharmacogenomics, in my opinion. The nurse also reassesses the effectiveness of medications that the patient is administered and communicate these to the physician. Nurses are the forerunner for advocacy if the medication is not working well and look for alternatives that may act as a synergist or enhancement.
NURS 4005 – Week 2 Discussion – Providing Genetic Nursing Care to Patients With Chronic Illnesses
Although these new developments in medicine create possibilities for health treatment and disease prevention, challenges arise just the same. Ethical issues that involve the patient and the healthcare providers may include topics within privacy and confidentiality, acts of discrimination, and access to treatment (Lea, 2008). Questions such as, who should have access to this information? Where should this information be kept, and is it safe? What guidelines prevent discrimination by potential employers and insurance companies? Will insurance providers cover these types of medications? Although this is a great theory, especially when treating chronic illnesses such as HIV/AIDS, cancer and other autoimmune diseases, proper guidelines must be addressed to ensure equal and unbiased care is provided.
References
Lea, D.H., 2008. Genetic and genomic healthcare: Ethical issues of importance to nurses” OJIN: The Online Journal of Issues in Nursing. Vol. 13 No. 1 Manuscript 4. DOI: 10.3912/OJIN.Vol13No01Man04
Pranavchand, R., & Reddy, B. M. (2016). Genomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancers. Journal of Postgraduate Medicine, 62(3), 188–198. https://doi- org.ezp.waldenulibrary.org/10.4103/0022-3859.186390
Veilleux, S. S. V. ulaval. c., Bouffard, M., & Bouliane, M.B., (2020). Patient and health care provider needs and preferences in understanding pharmacogenomic and genomic testing: A meta-data analysis. Qualitative Health Research, 30(1), 43–59. https://doi- org.ezp.waldenulibrary.org/10.1177/1049732319858325
ORDER A PLAGIARISM-FREE PAPER HERE
We’ll write everything from scratch
Question
NURS 4005 – Week 2 Discussion – Providing Genetic Nursing Care to Patients With Chronic Illnesses
Identify your subtopic and provide a brief summary of your journal article on how this topic relates to nursing practice. What is the nurse’s role in providing care in relation to your subtopic and the overarching theme of advocacy? What ethical implications should be considered with regard to genetics and genomics for nursing practice? Why?